← Back to Screener
Pro-Dex Inc New (PDEX)
Price$53.30
Favorite Metrics
Price vs S&P 500 (26W)51.47%
Price vs S&P 500 (4W)5.25%
Market Capitalization$174.44M
P/E Ratio (Annual)19.43x
All Metrics
Book Value / Share (Quarterly)$12.97
P/TBV (Annual)3.89x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)16.57%
Cash Flow / Share (Quarterly)$1.88
Price vs S&P 500 (YTD)34.64%
Gross Margin (TTM)28.29%
Net Profit Margin (TTM)15.73%
EPS (TTM)$3.40
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$3.40
Revenue Growth (5Y)13.84%
EPS (Annual)$2.67
ROI (Annual)17.26%
Gross Margin (Annual)29.30%
Net Profit Margin (5Y Avg)11.97%
Cash / Share (Quarterly)$2.75
P/E Basic Excl Extra (TTM)15.38x
Revenue Growth QoQ (YoY)11.14%
EPS Growth (5Y)12.27%
P/E Normalized (Annual)19.43x
ROA (Last FY)14.67%
Revenue Growth TTM (YoY)18.19%
EBITD / Share (TTM)$3.78
ROE (5Y Avg)20.50%
Operating Margin (TTM)15.74%
Cash Flow / Share (Annual)$-0.90
P/B Ratio4.19x
P/B Ratio (Quarterly)3.02x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.45x
Net Interest Coverage (TTM)1.58x
ROA (TTM)18.00%
EPS Growth QoQ (YoY)8.28%
EV / EBITDA (TTM)14.04x
EPS Incl Extra (Annual)$2.67
Current Ratio (Annual)3.23x
Quick Ratio (Quarterly)2.22x
3-Month Avg Trading Volume0.03M
52-Week Price Return-12.93%
EV / Free Cash Flow (Annual)10.00x
P/E Incl Extra (TTM)15.38x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$12.97
P/S Ratio (Annual)2.62x
Asset Turnover (Annual)1.09x
52-Week High$70.26
Operating Margin (5Y Avg)13.19%
EPS Excl Extra (Annual)$2.67
CapEx CAGR (5Y)19.10%
Tangible BV CAGR (5Y)14.12%
26-Week Price Return60.22%
Quick Ratio (Annual)1.69x
13-Week Price Return29.99%
Total Debt / Equity (Annual)0.42x
Current Ratio (Quarterly)4.03x
Enterprise Value$176.959
Revenue / Share Growth (5Y)18.34%
Asset Turnover (TTM)1.14x
Book Value / Share Growth (5Y)17.55%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.51x
Pretax Margin (Annual)18.11%
Cash / Share (Annual)$2.20
3-Month Return Std Dev42.75%
Gross Margin (5Y Avg)30.18%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)6.79%
EBITDA Interim CAGR (5Y)38.94%
ROE (Last FY)24.51%
Net Interest Coverage (Annual)9.85x
EPS Basic Excl Extra (Annual)$2.67
P/FCF (TTM)27.74x
Receivables Turnover (TTM)3.95x
EV / Free Cash Flow (TTM)29.39x
Total Debt / Equity (Quarterly)0.25x
EPS Incl Extra (TTM)$3.40
Receivables Turnover (Annual)4.36x
ROI (TTM)21.35%
P/S Ratio (TTM)2.42x
Pretax Margin (5Y Avg)15.41%
Revenue / Share (Annual)$19.81
Tangible BV / Share (Annual)$11.23
Forward P/E22.39x
Price vs S&P 500 (52W)-48.02%
P/E Ratio (TTM)15.38x
EPS Growth TTM (YoY)69.60%
Year-to-Date Return38.77%
5-Day Price Return1.91%
EPS Normalized (Annual)$2.67
ROA (5Y Avg)11.39%
Net Profit Margin (Annual)13.48%
Month-to-Date Return8.71%
Cash Flow / Share (TTM)$1.76
EBITD / Share (Annual)$3.55
EPS Growth (3Y)30.01%
Operating Margin (Annual)16.05%
LT Debt / Equity (Annual)0.25x
P/CF (TTM)26.99x
ROI (5Y Avg)13.74%
P/E Excl Extra (TTM)15.38x
LT Debt / Equity (Quarterly)0.19x
EPS Basic Excl Extra (TTM)$3.40
P/TBV (Quarterly)3.02x
P/B Ratio (Annual)3.88x
Inventory Turnover (TTM)2.50x
Pretax Margin (TTM)21.22%
Book Value / Share (Annual)$11.23
Price vs S&P 500 (13W)27.13%
Net Margin Growth (5Y)-5.13%
Beta-0.05x
P/FCF (Annual)33.28x
Revenue / Share (TTM)$21.82
ROE (TTM)29.25%
52-Week Low$23.47
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
PDEXPro-Dex Inc New | 2.42x | 13.84% | 28.29% | 15.74% | $53.30 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Pro-Dex designs and manufactures powered surgical instruments for medical device OEMs globally, specializing in autoclavable, battery-powered drivers and shavers used in orthopedic, thoracic, and craniomaxillofacial procedures. The company also provides engineering and regulatory consulting services and manufactures rotary air motors for industrial applications. Based in ISO-certified California facilities, Pro-Dex serves hospitals, medical labs, and manufacturers worldwide.